Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
'Far too speculative': Amgen fights FTC's request for injunction against $28B Horizon merger
Fierce Pharma
Thu, 08/24/23 - 11:38 am
Tags:
Amgen
,
Horizon Therapeutics
,
M&A
,
FTC
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
Tags:
patent cliff
,
patents
,
Takeda
,
Vyvanse
,
Pfizer
,
Eraxis
,
JNJ
,
Stelara
,
Merck
,
Isentress
,
Eiger Pharmaceuticals
,
Zokinvy
,
Astellas
,
Myrbetriq
,
Novartis
,
Entresto
,
Amgen
,
Otzela
KRAS crisis? FDA will gather advisers to weigh full approval for Amgen's Lumakras
Fierce Pharma
Mon, 08/21/23 - 06:56 pm
Tags:
Amgen
,
Lumakras
,
KRAS inhibitors
,
FDA
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
Tags:
CMS
,
Medicare
,
drug pricing
,
Bristol Myers Squibb
,
Janssen
,
Merck
,
Pfizer
,
Amgen
,
Boehringer Ingelheim
,
Pharmacyclics
,
AstraZeneca
,
Astellas
,
GSK
Mirati CEO Steps Down After Going Toe-to-Toe with Amgen in KRAS
BioSpace
Wed, 08/9/23 - 11:55 am
Tags:
Mirati Therapeutics
,
Pharma CEOs
,
David Meek
,
Amgen
,
KRAS inhibitors
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
BioSpace
Fri, 08/4/23 - 12:30 pm
Tags:
Amgen
,
oncology
,
colorectal cancer
,
small cell lung cancer
,
tarlatamab
,
Lumakras
Amgen's hyped Humira biosimilar fritters away its exclusivity advantage
Fierce Pharma
Fri, 08/4/23 - 11:56 am
Tags:
Amgen
,
AbbVie
,
biosimilars
,
Humira
Amgen's tarlatamab BiTEs at small cell lung cancer in brief readout
Fierce Biotech
Thu, 08/3/23 - 06:37 pm
Tags:
Amgen
,
tarlatamab
,
small cell lung cancer
,
T-cells
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars
,
Humira
,
AbbVie
,
rebates
,
drug pricing
,
Amgen
,
Celltrion
,
Novartis
,
Boehringer Ingelheim
,
Biocon
,
Fresenius
,
Sandoz
,
Organon
,
Coherus
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
Tags:
AbbVie
,
Skyrizi
,
Amgen
,
Otezla
,
Boehringer Ingelheim
,
psoriasis
Amgen’s lupus bets continue to flounder, even those on the Horizon
Fierce Biotech
Mon, 07/24/23 - 10:24 am
Tags:
Horizon Therapeutics
,
Amgen
,
lupus
,
daxdilimab
,
clinical trials
FTC, Amgen Break Off Settlement Talks Over Horizon Deal
BioSpace
Thu, 07/20/23 - 10:07 am
Tags:
Amgen
,
Horizon Therapeutics
,
M&A
,
FTC
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
Tags:
M&A
,
Amgen
,
Astellas
,
Eli Lilly
,
GSK
,
Horizon Therapeutics
,
Merck
,
Novartis
,
Pfizer
,
Seagen
States Back FTC in Lawsuit Seeking to Block Amgen-Horizon Deal
BioSpace
Fri, 06/23/23 - 09:53 am
Tags:
Amgen
,
Horizon Therapeutics
,
M&A
,
FTC
Amgen granted full FDA approval for blood cancer treatment
Biopharma Reporter
Thu, 06/22/23 - 10:10 am
Tags:
Amgen
,
Blincyto
,
FDA
,
blood cancer
Full circle for Paul Burton as Moderna exec returns to Amgen, this time for expanded CMO role
Fierce Biotech
Wed, 06/14/23 - 06:33 pm
Tags:
Amgen
,
Moderna Therapeutics
,
Paul Burton
,
chief medical officers
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Sun, 06/11/23 - 11:02 pm
Tags:
Medicare
,
Inflation Reduction Act
,
drug pricing
,
Amgen
,
Sanofi
,
Seagen
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
Tags:
biosimilars
,
biologics
,
drug pricing
,
Roche
,
Herceptin
,
Amgen
,
Kanjinti
,
Viatris
,
Ogivri
,
Pfizer
,
Trazimera
,
Teva Pharmaceutical
,
Herzuma
,
Organon
,
Ontruzant
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
BioSpace
Wed, 06/7/23 - 11:15 am
Tags:
Amgen
,
Horizon Therapeutics
,
FTC
,
M&A
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Mon, 06/5/23 - 10:21 am
Tags:
Amgen
,
Horizon Therapeutics
,
FTC
,
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.